MedPath

SHAROBEL

SHAROBEL™(Norethindrone Tablets, USP)

Approved
Approval ID

a96f5194-ad2a-4783-a9a9-22a288caff25

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 30, 2023

Manufacturers
FDA

Northstar Rx LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16714-441
Application NumberANDA200961
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone
Product Specifications
Effective DateMay 23, 2016
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.